Parkinson DiseaseNCT04283812
New Stereotactic Frame System for Neurosurgery
A study testing DBS Electrode Implantation using D1 Sterotactic System in people with Parkinson Disease and Essential Tremor, run by Mayo Clinic.
Trial summary
This study is designed to demonstrate an in-house developed re-attachable stereotactic system that can markedly reduce the overall deep brain stimulation (DBS) procedure time to greatly facilitate subject access to neurosurgical restorative therapies. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Parkinson Disease, Essential Tremor, Dystonia
- What is being tested?
- DBS Electrode Implantation using D1 Sterotactic System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Jan 2023to Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Must be adult subjects with medically intractable neurological disorder who have been approved for DBS surgery by the interdisciplinary Mayo DBS committee.
- Competent and willing to provide signed, informed consent to participate in the study.
- Competent and willing to provide written, informed consent to participate in the study.
Who cannot join
- Pregnant subjects, prisoners, individuals ages less than 18 and any subjects identified as unsuitable for DBS surgery by the Mayo Clinic DBS committee.
- Subjects unable to communicate with the investigator and staff.
- Any health condition that in the investigator's opinion should preclude participation in this study.
About this study
Official title: A Re-attachable Stereotactic Frame System for Clinical Interventive Neurosurgery
This study is designed to demonstrate an in-house developed re-attachable stereotactic system that can markedly reduce the overall deep brain stimulation (DBS) procedure time to greatly facilitate subject access to neurosurgical restorative therapies. Subjects will consist exclusively of individuals who have been approved to undergo deep brain stimulation surgery for the treatment of a neurological disorder at Mayo Clinic - Rochester MN. This study is a quantitative comparative, between-subject study enrolling approximately 10 subjects.
Read the detailed description
Aims:
This study will evaluate a new stereotactic device (D1 stereotactic system) designed to address shortcomings of current stereotactic systems by using a novel surface-mounted stereotactic system that is comparatively small, lightweight, user-friendly, and comparable in precision and accuracy to current clinical systems.
Methods:
Subjects will be recruited exclusively from adult subjects with a neurological disease. These subjects will be identified preoperatively from DBS clinical subjects. Each subject will undergo an evaluation by the Mayo Clinic Deep Brain Stimulation Committee (comprised of neurologists, neuropsychologists, psychiatrists, neurosurgeons, and radiologists) to receive a DBS surgery at Mayo Clinic - Rochester for the treatment of a neurological disease. All subjects will be pre-screened against the standard Mayo Clinic inclusion/exclusion criteria for DBS surgery through face-to-face interviews. Once a subject has been identified, the Study Coordinator will contact the subject for interest in participation in the study.
Step-by-Step Schedule:
Skull Anchor Key Attachment Location: St. Mary Hospital - Subject Preparation Room
- Superior portion of the head, the hair is clipped off in the area where Skull Anchor Key would be placed. The clipped area and surrounding region is prepped in usual sterile fashion. This begins subject participation in the protocol.
- The MR Localizer Box is placed upside down and the Skull Anchor Key is placed within its slot in the MR Localizer Box and screwed in using MR compatible screws.
- The apparatus is positioned on the subject head and allowed to rest such that the Skull Anchor Key is midline and the ear bars lie parallel to the external auditory meatus taking caution to prevent the bottom surface of the Skull Anchor Key or the safety caps from becoming non sterile.
- The Z value of the ear bars is adjusted such that the ear probes are at same horizontal level as the external auditory meatus. The ear bars are gently pushed into the external auditory meatus on both sides such that it is snug but comfortable to the subject. (NOTE: If required, the Y position of the ear bars may be readjusted at this step in situations such as the anterior N fiducial bars hitting the forehead of the subject).
- After confirming accurate initial placement of the MR Localizer Box, the sites of skull screw and pins placement are marked using a surgical pen with the guide Skull Anchor Key which has holes instead of screws and pins acting as reference guide. The MR Localizer Box is then removed and each of the pen marked site receives an injection of local anesthetic.
- Following local anesthetic application, the ear bars are removed from the ear while an assistant supports the MR Localizer Box. The MR Localizer Box is gradually lowered to allow the pins to penetrate scalp until it rests on the bone. At this point, titanium self-tapping screws are gently screwed in through the hole on each of the 2 angled legs of the Skull Anchor Key until the Skull Anchor Key is level and secure.
- The subject is then transferred to the MR/CT Imaging Facility for target planning.
MRI Acquisition and Target Planning Location: St. Mary Hospital - Neuroradiology Facility
- Once in MR suite, the subject rests their head in a custom made MR headrest which sits within the lower portion of RF coil. The headrest holds the axis of MR Localizer Box parallel to the axis of MR gantry and allows the frame to be held securely during the MR imaging.
- The subject is positioned in a MR scanner in a supine position.
- An anatomical image volume is acquired. The field of view region is adjusted to ensure the MR Localizer Box fiducials are visible in the MR images and then all images are acquired.
- The images are then transferred to the surgical planning computer.
- Following image acquisition, the images are reviewed by the surgical team to judge whether they are suitable for surgical planning. (If found unsuitable, the imaging and review is repeated.) Once satisfactory images are obtained, the subject is moved to the subject preparation room where the MR Localizer Box is detached from the KEY.
- A DBS surgical plan, comprised of the electrode stereotactic target coordinates and an optimal trajectory is created by the navigational software. The plan is documented and shared with the surgical team.
- The subject is then transferred to the operating room for DBS electrode implantation.
DBS Electrode Implantation Location: St. Mary Hospital - Operating Room
- The subject is shifted to the operating room.
- The D1 stereotactic device is attached to the Skull Anchor Key and the X, Y, Z, Arc and Collar angles will be adjusted based on MR planned coordinates.
- Standard procedure is followed for making the incision and burr hole, putting in the DBS electrode, electrophysiologic target confirmation (as required) and securing the electrode in place.
- A C-arm is then used to obtain a lateral view radiograph to confirm correct placement of the DBS electrode as assessed by the alignment of the tip of the DBS electrode with X-ray reticules on the stereotactic device.
- Above steps are repeated for additional DBS electrode insertion.
- After securing the last DBS electrode the stereotactic device is removed from the KEY. All DBS electrodes are then coiled and secured under the skin or are tunneled beneath the skin of the scalp and neck for battery placement as currently practiced. All surgical incisions are then sutured.
- The CT Localizer Box is attached to the Skull Anchor Key to acquire a post-operative CT scan.
- The subject is then transferred to the Neuroradiology Facility for post-operative CT imaging.
CT Confirmation and CT Localizer Box and KEY Removal Location: St. Mary Hospital - Neuroradiology Facility
- With the subject in the CT imaging room the subject is positioned supine in the CT scanner to acquire a postoperative anatomical image volume to confirm the placement of the DBS electrode placement using planning software normally used for neurosurgical procedures.
- Immediately following the CT scan, the subject is taken to the preparation room for removal of the CT Localizer Box, the Skull Anchor Key, and post-removal treatments. The self-tapping titanium screws are removed and the surgical site is treated appropriately.
Power Statement:
This is a pilot study with a unique subject cohort.
Data Analysis Plan:
The effectiveness of the D1 Stereotactic System in accurately implanting DBS electrodes in adults approved for DBS surgery at Mayo Clinic for treatment of a neurological disease will be evaluated by analyzing the following:
- A 3D Euclidian distance error between the MR planned coordinate (XP, YP, ZP) and CT confirmed actual DBS coordinate (XA, YA, ZA) will be calculated. The 3D distance error comparable or lower to conventional system will be accounted as success criteria. Unpaired t-test will be used to determine whether the difference is significantly different or not.
- A trajectory accuracy will be determined by comparing Collar Angle (CA) and Arc Angle (AA) between MR planned angles (CAP and AAP) and CT confirmed actual angles (CAA and AAA). The non-significant difference between MR planned and CT confirmed angles will be accounted as success criteria. Paired t-test will be used for 10 patient data.
- Operating room time will be counted and compared to conventional procedure (using Leksell frame). The average operating room time will be compared between conventional procedure and D1 Stereotactic System procedure. Significantly lower operating room time will be accounted as success criteria.
- Comfort level questionnaire will be given to each subject after DBS surgery and removal of the device to assess their overall experience with device and surgery.
Data Exclusion Criteria: If any surgical plan is changed in operating room (i.e., target coordinate, trajectory), the data will be excluded. However, the change of DBS electrode depth will be accounted as valid data.
- Conditions
- Parkinson Disease, Essential Tremor, Dystonia, Tourette Syndrome, Obsessive-Compulsive Disorder
- Being tested
- DBS Electrode Implantation using D1 Sterotactic System
- Keywords
- deep brain stimulation, sterotactic surgery, neurological disorders, stereotactic instruments
- Medical subject headings
- Parkinson Disease, Essential Tremor, Dystonia, Tourette Syndrome, Obsessive-Compulsive Disorder, Nervous System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DBS Electrode Implantation using D1 Sterotactic SystemDevice
Treatment intervention will consist of subjects undergoing Mayo Clinic standard deep brain stimulation surgery specific to their diagnosed neurological disorder consisting of implantation of stimulating electrodes using the D1 stereotactic system.
| Study group | Role | What they receive |
|---|---|---|
| D1 Stereotactic System Assessment | Experimental | Participants in the clinical study will consist of subjects approved to undergo deep brain stimulation surgery for the treatment of a neurological disorder at Mayo Clinic. Subjects will have a Key secured to their skull for attachment of an MRI-compatible localizer box or D1 stereotactic frame. 3D Euclidian distance error(s), trajectory accuracy(s), operating room time, and comfort level of the system will be assessed. Receives: Device: DBS Electrode Implantation using D1 Sterotactic System |
What is being measured
The primary outcome is the main question the study is designed to answer.
3D Euclidian distance error
3D Euclidian distance error between the MR planned coordinate (XP, YP, ZP) and CT confirmed actual DBS coordinate (XA, YA, ZA) will be calculated. The 3D distance error comparable or lower to conventional system will be accounted as success criteria.
Measured: Within 1 month post-DBS surgery.
Trajectory accuracy
A trajectory accuracy will be determined by comparing Collar Angle (CA) and Arc Angle (AA) between MR planned angles (CAP and AAP) and CT confirmed actual angles (CAA and AAA). The non-significant difference between MR planned and CT confirmed angles will be accounted as success criteria.
Measured: Within 1 month post-DBS surgery.
Operating room time
Operating room time will be counted and compared to conventional procedure (using Leksell frame). The average operating room time will be compared between conventional procedure and D1 Stereotactic System procedure. Significantly lower operating room time will be accounted as success criteria
Measured: Within 1 month post-DBS surgery.
Comfort level questionnaire
Comfort level questionnaire will be given to each subject after DBS surgery and removal of the device to assess their overall experience with device and surgery.
Measured: Within 1 month post-DBS surgery.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Feb 2020
- Study startJan 2023 (estimated)
- Primary completionJun 2023 (estimated)
- Study completionJun 2023 (estimated)
Why it stopped: Per PI discretion, study closed and no participants enrolled
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (13)Papers the sponsor has linked to this study.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Collaborators
- NaviNetics Inc.
- Responsible party
- Principal investigator, Kai J. Miller, Mayo Clinic
- Investigators
- Kai Miller, MD, PhD, Principal investigator, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04283812
- Sponsor's protocol ID
- 18-011914
- Status last verified
- Aug 2022
- First submitted
- 23 Feb 2020
- Last updated
- 3 Aug 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Ben-Haim S, Falowski SM. Evaluation of Patient Perspectives Toward Awake, Frame-Based Deep-Brain Stimulation Surgery. World Neurosurg. 2018 Mar;111:e601-e607. doi: 10.1016/j.wneu.2017.12.122. Epub 2017 Dec 28.
PubMed 29288853Bjartmarz H, Rehncrona S. Comparison of accuracy and precision between frame-based and frameless stereotactic navigation for deep brain stimulation electrode implantation. Stereotact Funct Neurosurg. 2007;85(5):235-42. doi: 10.1159/000103262. Epub 2007 May 25.
PubMed 17534136Bot M, van den Munckhof P, Bakay R, Sierens D, Stebbins G, Verhagen Metman L. Analysis of Stereotactic Accuracy in Patients Undergoing Deep Brain Stimulation Using Nexframe and the Leksell Frame. Stereotact Funct Neurosurg. 2015;93(5):316-25. doi: 10.1159/000375178. Epub 2015 Jul 29.
PubMed 26227179Edwards CA, Rusheen AE, Oh Y, Paek SB, Jacobs J, Lee KH, Dennis KD, Bennet KE, Kouzani AZ, Lee KH, Goerss SJ. A novel re-attachable stereotactic frame for MRI-guided neuronavigation and its validation in a large animal and human cadaver model. J Neural Eng. 2018 Dec;15(6):066003. doi: 10.1088/1741-2552/aadb49. Epub 2018 Aug 20.
PubMed 30124202Goerss S, Kelly PJ, Kall B, Alker GJ Jr. A computed tomographic stereotactic adaptation system. Neurosurgery. 1982 Mar;10(3):375-9. doi: 10.1227/00006123-198203000-00014.
PubMed 7041006Grahn PJ, Goerss SJ, Lujan JL, Mallory GW, Kall BA, Mendez AA, Trevathan JK, Felmlee JP, Bennet KE, Lee KH. MRI-Guided Stereotactic System for Delivery of Intraspinal Microstimulation. Spine (Phila Pa 1976). 2016 Jul 1;41(13):E806-E813. doi: 10.1097/BRS.0000000000001397.
PubMed 26679880Kelly PJ, Kall BA, Goerss S. Computer simulation for the stereotactic placement of interstitial radionuclide sources into computed tomography-defined tumor volumes. Neurosurgery. 1984 Apr;14(4):442-8. doi: 10.1227/00006123-198404000-00009.
PubMed 6374493Kelly PJ, Sharbrough FW, Kall BA, Goerss SJ. Magnetic resonance imaging-based computer-assisted stereotactic resection of the hippocampus and amygdala in patients with temporal lobe epilepsy. Mayo Clin Proc. 1987 Feb;62(2):103-8. doi: 10.1016/s0025-6196(12)61877-1.
PubMed 3543519Knight EJ, Min HK, Hwang SC, Marsh MP, Paek S, Kim I, Felmlee JP, Abulseoud OA, Bennet KE, Frye MA, Lee KH. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS One. 2013;8(2):e56640. doi: 10.1371/journal.pone.0056640. Epub 2013 Feb 18.
PubMed 23441210Konrad PE, Neimat JS, Yu H, Kao CC, Remple MS, D'Haese PF, Dawant BM. Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg. 2011;89(1):34-41. doi: 10.1159/000322276. Epub 2010 Dec 15.
PubMed 21160241Min HK, Ross EK, Lee KH, Dennis K, Han SR, Jeong JH, Marsh MP, Striemer B, Felmlee JP, Lujan JL, Goerss S, Duffy PS, Blaha C, Chang SY, Bennet KE. Subthalamic nucleus deep brain stimulation induces motor network BOLD activation: use of a high precision MRI guided stereotactic system for nonhuman primates. Brain Stimul. 2014 Jul-Aug;7(4):603-607. doi: 10.1016/j.brs.2014.04.007. Epub 2014 May 2.
PubMed 24933029Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson's disease: the role of the primary care physician. Geriatrics. 2007 May;62(5):18-24.
PubMed 17489644Wang DD, Lau D, Rolston JD, Englot DJ, Sneed PK, McDermott MW. Pain experience using conventional versus angled anterior posts during stereotactic head frame placement for radiosurgery. J Clin Neurosci. 2014 Sep;21(9):1538-42. doi: 10.1016/j.jocn.2014.02.009. Epub 2014 May 6.
PubMed 24814855
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Re-attachable Stereotactic Frame System for Clinical Interventive Neurosurgery
- ClinicalTrials.gov ID
- NCT04283812
- Acronym / sponsor ID
- 18-011914
- Conditions
- Parkinson Disease, Essential Tremor, Dystonia, Tourette Syndrome, Obsessive-Compulsive Disorder
- Keywords
- deep brain stimulation, sterotactic surgery, neurological disorders, stereotactic instruments
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Per PI discretion, study closed and no participants enrolled
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Collaborators
- NaviNetics Inc.
- Study start
- Jan 2023 (estimated)
- Primary completion
- Jun 2023 (estimated)
- Study completion
- Jun 2023 (estimated)
- First posted
- 25 Feb 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is designed to demonstrate an in-house developed re-attachable stereotactic system that can markedly reduce the overall deep brain stimulation (DBS) procedure time to greatly facilitate subject access to neurosurgical restorative therapies. Subjects will consist exclusively of individuals who have been approved to undergo deep brain stimulation surgery for the treatment of a neurological disorder at Mayo Clinic - Rochester MN. This study is a quantitative comparative, between-subject study enrolling approximately 10 subjects.
Detailed description
Aims:
This study will evaluate a new stereotactic device (D1 stereotactic system) designed to address shortcomings of current stereotactic systems by using a novel surface-mounted stereotactic system that is comparatively small, lightweight, user-friendly, and comparable in precision and accuracy to current clinical systems.
Methods:
Subjects will be recruited exclusively from adult subjects with a neurological disease. These subjects will be identified preoperatively from DBS clinical subjects. Each subject will undergo an evaluation by the Mayo Clinic Deep Brain Stimulation Committee (comprised of neurologists, neuropsychologists, psychiatrists, neurosurgeons, and radiologists) to receive a DBS surgery at Mayo Clinic - Rochester for the treatment of a neurological disease. All subjects will be pre-screened against the standard Mayo Clinic inclusion/exclusion criteria for DBS surgery through face-to-face interviews. Once a subject has been identified, the Study Coordinator will contact the subject for interest in participation in the study.
Step-by-Step Schedule:
Skull Anchor Key Attachment Location: St. Mary Hospital - Subject Preparation Room
- Superior portion of the head, the hair is clipped off in the area where Skull Anchor Key would be placed. The clipped area and surrounding region is prepped in usual sterile fashion. This begins subject participation in the protocol.
- The MR Localizer Box is placed upside down and the Skull Anchor Key is placed within its slot in the MR Localizer Box and screwed in using MR compatible screws.
- The apparatus is positioned on the subject head and allowed to rest such that the Skull Anchor Key is midline and the ear bars lie parallel to the external auditory meatus taking caution to prevent the bottom surface of the Skull Anchor Key or the safety caps from becoming non sterile.
- The Z value of the ear bars is adjusted such that the ear probes are at same horizontal level as the external auditory meatus. The ear bars are gently pushed into the external auditory meatus on both sides such that it is snug but comfortable to the subject. (NOTE: If required, the Y position of the ear bars may be readjusted at this step in situations such as the anterior N fiducial bars hitting the forehead of the subject).
- After confirming accurate initial placement of the MR Localizer Box, the sites of skull screw and pins placement are marked using a surgical pen with the guide Skull Anchor Key which has holes instead of screws and pins acting as reference guide. The MR Localizer Box is then removed and each of the pen marked site receives an injection of local anesthetic.
- Following local anesthetic application, the ear bars are removed from the ear while an assistant supports the MR Localizer Box. The MR Localizer Box is gradually lowered to allow the pins to penetrate scalp until it rests on the bone. At this point, titanium self-tapping screws are gently screwed in through the hole on each of the 2 angled legs of the Skull Anchor Key until the Skull Anchor Key is level and secure.
- The subject is then transferred to the MR/CT Imaging Facility for target planning.
MRI Acquisition and Target Planning Location: St. Mary Hospital - Neuroradiology Facility
- Once in MR suite, the subject rests their head in a custom made MR headrest which sits within the lower portion of RF coil. The headrest holds the axis of MR Localizer Box parallel to the axis of MR gantry and allows the frame to be held securely during the MR imaging.
- The subject is positioned in a MR scanner in a supine position.
- An anatomical image volume is acquired. The field of view region is adjusted to ensure the MR Localizer Box fiducials are visible in the MR images and then all images are acquired.
- The images are then transferred to the surgical planning computer.
- Following image acquisition, the images are reviewed by the surgical team to judge whether they are suitable for surgical planning. (If found unsuitable, the imaging and review is repeated.) Once satisfactory images are obtained, the subject is moved to the subject preparation room where the MR Localizer Box is detached from the KEY.
- A DBS surgical plan, comprised of the electrode stereotactic target coordinates and an optimal trajectory is created by the navigational software. The plan is documented and shared with the surgical team.
- The subject is then transferred to the operating room for DBS electrode implantation.
DBS Electrode Implantation Location: St. Mary Hospital - Operating Room
- The subject is shifted to the operating room.
- The D1 stereotactic device is attached to the Skull Anchor Key and the X, Y, Z, Arc and Collar angles will be adjusted based on MR planned coordinates.
- Standard procedure is followed for making the incision and burr hole, putting in the DBS electrode, electrophysiologic target confirmation (as required) and securing the electrode in place.
- A C-arm is then used to obtain a lateral view radiograph to confirm correct placement of the DBS electrode as assessed by the alignment of the tip of the DBS electrode with X-ray reticules on the stereotactic device.
- Above steps are repeated for additional DBS electrode insertion.
- After securing the last DBS electrode the stereotactic device is removed from the KEY. All DBS electrodes are then coiled and secured under the skin or are tunneled beneath the skin of the scalp and neck for battery placement as currently practiced. All surgical incisions are then sutured.
- The CT Localizer Box is attached to the Skull Anchor Key to acquire a post-operative CT scan.
- The subject is then transferred to the Neuroradiology Facility for post-operative CT imaging.
CT Confirmation and CT Localizer Box and KEY Removal Location: St. Mary Hospital - Neuroradiology Facility
- With the subject in the CT imaging room the subject is positioned supine in the CT scanner to acquire a postoperative anatomical image volume to confirm the placement of the DBS electrode placement using planning software normally used for neurosurgical procedures.
- Immediately following the CT scan, the subject is taken to the preparation room for removal of the CT Localizer Box, the Skull Anchor Key, and post-removal treatments. The self-tapping titanium screws are removed and the surgical site is treated appropriately.
Power Statement:
This is a pilot study with a unique subject cohort.
Data Analysis Plan:
The effectiveness of the D1 Stereotactic System in accurately implanting DBS electrodes in adults approved for DBS surgery at Mayo Clinic for treatment of a neurological disease will be evaluated by analyzing the following:
- A 3D Euclidian distance error between the MR planned coordinate (XP, YP, ZP) and CT confirmed actual DBS coordinate (XA, YA, ZA) will be calculated. The 3D distance error comparable or lower to conventional system will be accounted as success criteria. Unpaired t-test will be used to determine whether the difference is significantly different or not.
- A trajectory accuracy will be determined by comparing Collar Angle (CA) and Arc Angle (AA) between MR planned angles (CAP and AAP) and CT confirmed actual angles (CAA and AAA). The non-significant difference between MR planned and CT confirmed angles will be accounted as success criteria. Paired t-test will be used for 10 patient data.
- Operating room time will be counted and compared to conventional procedure (using Leksell frame). The average operating room time will be compared between conventional procedure and D1 Stereotactic System procedure. Significantly lower operating room time will be accounted as success criteria.
- Comfort level questionnaire will be given to each subject after DBS surgery and removal of the device to assess their overall experience with device and surgery.
Data Exclusion Criteria: If any surgical plan is changed in operating room (i.e., target coordinate, trajectory), the data will be excluded. However, the change of DBS electrode depth will be accounted as valid data.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| D1 Stereotactic System Assessment | Experimental | Device: DBS Electrode Implantation using D1 Sterotactic SystemParticipants in the clinical study will consist of subjects approved to undergo deep brain stimulation surgery for the treatment of a neurological disorder at Mayo Clinic. Subjects will have a Key secured to their skull for attachment of an MRI-compatible localizer box or D1 stereotactic frame. 3D Euclidian distance error(s), trajectory accuracy(s), operating room time, and comfort level of the system will be assessed. |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Must be adult subjects with medically intractable neurological disorder who have been approved for DBS surgery by the interdisciplinary Mayo DBS committee.
- Competent and willing to provide signed, informed consent to participate in the study.
- Competent and willing to provide written, informed consent to participate in the study.
Key exclusion criteria (3 listed)
- Pregnant subjects, prisoners, individuals ages less than 18 and any subjects identified as unsuitable for DBS surgery by the Mayo Clinic DBS committee.
- Subjects unable to communicate with the investigator and staff.
- Any health condition that in the investigator's opinion should preclude participation in this study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DBS Electrode Implantation using D1 Sterotactic SystemTreatment intervention will consist of subjects undergoing Mayo Clinic standard deep brain stimulation surgery specific to their diagnosed neurological disorder consisting of implantation of stimulating electrodes using the D1 stereotactic system. | Device | D1 Stereotactic System Assessment |
Primary outcome
3D Euclidian distance error
Time frame: Within 1 month post-DBS surgery.
3D Euclidian distance error between the MR planned coordinate (XP, YP, ZP) and CT confirmed actual DBS coordinate (XA, YA, ZA) will be calculated. The 3D distance error comparable or lower to conventional system will be accounted as success criteria.
Trajectory accuracy
Time frame: Within 1 month post-DBS surgery.
A trajectory accuracy will be determined by comparing Collar Angle (CA) and Arc Angle (AA) between MR planned angles (CAP and AAP) and CT confirmed actual angles (CAA and AAA). The non-significant difference between MR planned and CT confirmed angles will be accounted as success criteria.
Operating room time
Time frame: Within 1 month post-DBS surgery.
Operating room time will be counted and compared to conventional procedure (using Leksell frame). The average operating room time will be compared between conventional procedure and D1 Stereotactic System procedure. Significantly lower operating room time will be accounted as success criteria
Comfort level questionnaire
Time frame: Within 1 month post-DBS surgery.
Comfort level questionnaire will be given to each subject after DBS surgery and removal of the device to assess their overall experience with device and surgery.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2022.
- Background: PubMed 29288853Ben-Haim S, Falowski SM. Evaluation of Patient Perspectives Toward Awake, Frame-Based Deep-Brain Stimulation Surgery. World Neurosurg. 2018 Mar;111:e601-e607. doi: 10.1016/j.wneu.2017.12.122. Epub 2017 Dec 28.
- Background: PubMed 17534136Bjartmarz H, Rehncrona S. Comparison of accuracy and precision between frame-based and frameless stereotactic navigation for deep brain stimulation electrode implantation. Stereotact Funct Neurosurg. 2007;85(5):235-42. doi: 10.1159/000103262. Epub 2007 May 25.
- Background: PubMed 26227179Bot M, van den Munckhof P, Bakay R, Sierens D, Stebbins G, Verhagen Metman L. Analysis of Stereotactic Accuracy in Patients Undergoing Deep Brain Stimulation Using Nexframe and the Leksell Frame. Stereotact Funct Neurosurg. 2015;93(5):316-25. doi: 10.1159/000375178. Epub 2015 Jul 29.
- Background: PubMed 30124202Edwards CA, Rusheen AE, Oh Y, Paek SB, Jacobs J, Lee KH, Dennis KD, Bennet KE, Kouzani AZ, Lee KH, Goerss SJ. A novel re-attachable stereotactic frame for MRI-guided neuronavigation and its validation in a large animal and human cadaver model. J Neural Eng. 2018 Dec;15(6):066003. doi: 10.1088/1741-2552/aadb49. Epub 2018 Aug 20.
- Background: PubMed 7041006Goerss S, Kelly PJ, Kall B, Alker GJ Jr. A computed tomographic stereotactic adaptation system. Neurosurgery. 1982 Mar;10(3):375-9. doi: 10.1227/00006123-198203000-00014.
- Background: PubMed 26679880Grahn PJ, Goerss SJ, Lujan JL, Mallory GW, Kall BA, Mendez AA, Trevathan JK, Felmlee JP, Bennet KE, Lee KH. MRI-Guided Stereotactic System for Delivery of Intraspinal Microstimulation. Spine (Phila Pa 1976). 2016 Jul 1;41(13):E806-E813. doi: 10.1097/BRS.0000000000001397.
- Background: PubMed 6374493Kelly PJ, Kall BA, Goerss S. Computer simulation for the stereotactic placement of interstitial radionuclide sources into computed tomography-defined tumor volumes. Neurosurgery. 1984 Apr;14(4):442-8. doi: 10.1227/00006123-198404000-00009.
- Background: PubMed 3543519Kelly PJ, Sharbrough FW, Kall BA, Goerss SJ. Magnetic resonance imaging-based computer-assisted stereotactic resection of the hippocampus and amygdala in patients with temporal lobe epilepsy. Mayo Clin Proc. 1987 Feb;62(2):103-8. doi: 10.1016/s0025-6196(12)61877-1.
- Background: PubMed 23441210Knight EJ, Min HK, Hwang SC, Marsh MP, Paek S, Kim I, Felmlee JP, Abulseoud OA, Bennet KE, Frye MA, Lee KH. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS One. 2013;8(2):e56640. doi: 10.1371/journal.pone.0056640. Epub 2013 Feb 18.
- Background: PubMed 21160241Konrad PE, Neimat JS, Yu H, Kao CC, Remple MS, D'Haese PF, Dawant BM. Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg. 2011;89(1):34-41. doi: 10.1159/000322276. Epub 2010 Dec 15.
- Background: PubMed 24933029Min HK, Ross EK, Lee KH, Dennis K, Han SR, Jeong JH, Marsh MP, Striemer B, Felmlee JP, Lujan JL, Goerss S, Duffy PS, Blaha C, Chang SY, Bennet KE. Subthalamic nucleus deep brain stimulation induces motor network BOLD activation: use of a high precision MRI guided stereotactic system for nonhuman primates. Brain Stimul. 2014 Jul-Aug;7(4):603-607. doi: 10.1016/j.brs.2014.04.007. Epub 2014 May 2.
- Background: PubMed 17489644Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson's disease: the role of the primary care physician. Geriatrics. 2007 May;62(5):18-24.
- Mayo Clinic Clinical TrialsLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
RecruitingEarly Phase 1
[18F]ACI-15916 PET in α-synucleinopathies
Parkinson's Disease (PD), Multiple System Atrophy (MSA)
RecruitingPhase 2
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
RecruitingPhase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Carcinoma, Non-Small-Cell Lung
Not yet recruitingPhase 4
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Overactive Bladder, Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kai Miller, MD, PhD principal investigator
Mayo Clinic
Questions about this trial
What is this clinical trial studying?
A study testing DBS Electrode Implantation using D1 Sterotactic System in people with Parkinson Disease and Essential Tremor, run by Mayo Clinic.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 3 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
3D Euclidian distance error (time frame: Within 1 month post-DBS surgery.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04283812, which also lists 13 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2022; AzTrials last refreshed its copy on 29 Oct 2026.